Contract 75A50325C00002
Accord Biopharma, Inc. · Department Of Health And Human Services · March 19, 2025
Accord Biopharma, Inc. was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on March 19, 2025 for $19.42 million of work in pharmaceutical preparation manufacturing. Performance is in Redwood City, CA. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 18, 2026. If all options are exercised, the contract could reach $45.16 million.
Contract details
- PIID
- 75A50325C00002
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Redwood City, CA
- First action
- March 19, 2025
- Latest action
- March 18, 2026
Description
EXERCISE ORDERING PERIOD 1
Modification timeline
-
March 18, 2026Mod P00002$7.62M
-
March 6, 2026Mod P00001NOVATION AND CHANGE-OF-NAME AGREEMENT$0
-
March 19, 2025Base awardPEGFILGRASTIM 6MG/.06ML (INJ, SOLN, SYR OR AUTOINJECTOR) AND VMI$11.81M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 27, 2026 | $92.33M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50325C00002?
Contract 75A50325C00002 is a federal contract awarded to Accord Biopharma, Inc. by Department Of Health And Human Services on March 19, 2025 for $19.42 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 2 times since the base award.
Who won contract 75A50325C00002?
Accord Biopharma, Inc. won contract 75A50325C00002 from Department Of Health And Human Services.
How much is contract 75A50325C00002 worth?
Contract 75A50325C00002 has obligated $19.42 million to date, with a total potential value of $45.16 million if all options are exercised.